Annual Revenue
N/A
31 December 2023
Summary:
Oncolytics Biotech annual revenue is not available.ONCY Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 September 2024
Summary:
Oncolytics Biotech quarterly revenue is not available.ONCY Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 September 2024
Summary:
Oncolytics Biotech TTM revenue is not available.ONCY TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCY Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ONCY Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Oncolytics Biotech Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2007 | - | $305.40 K(+6.9%) | $305.40 K(-63.5%) |
| Sept 2006 | - | $285.70 K(-4.2%) | $837.00 K(+15.2%) |
| June 2006 | - | $298.30 K(+17.9%) | $726.80 K(+29.0%) |
| Mar 2006 | - | $253.00 K(+44.2%) | $563.40 K(+10.5%) |
| Sept 2005 | - | $175.50 K(+30.1%) | $510.00 K(-2.2%) |
| June 2005 | - | $134.90 K(-32.4%) | $521.50 K(0.0%) |
| Mar 2005 | - | $199.60 K(+6.7%) | $521.50 K(+2.8%) |
| Sept 2004 | - | $187.00 K(+38.6%) | $507.20 K(+28.7%) |
| June 2004 | - | $134.90 K(+51.6%) | $394.10 K(+36.5%) |
| Mar 2004 | - | $89.00 K(-7.6%) | $288.80 K(+26.4%) |
| Dec 2003 | $224.20 K | $96.30 K(+30.3%) | $228.40 K(+42.4%) |
| Sept 2003 | - | $73.90 K(+149.7%) | $160.40 K(+33.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2003 | - | $29.60 K(+3.5%) | $120.30 K(-4.3%) |
| Mar 2003 | - | $28.60 K(+1.1%) | $125.70 K(-5.5%) |
| Dec 2002 | $133.10 K(-36.3%) | $28.30 K(-16.3%) | $133.00 K(+27.0%) |
| Sept 2002 | - | $33.80 K(-3.4%) | $104.70 K(+47.7%) |
| June 2002 | - | $35.00 K(-2.5%) | $70.90 K(+97.5%) |
| Mar 2002 | - | $35.90 K(>+9900.0%) | $35.90 K(-82.3%) |
| June 2001 | - | $0.00(0.0%) | $203.20 K(0.0%) |
| Mar 2001 | - | $0.00(-100.0%) | $203.20 K(0.0%) |
| Dec 2000 | $208.80 K(>+9900.0%) | $203.20 K(>+9900.0%) | $203.20 K(>+9900.0%) |
| Sept 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2000 | - | $0.00 | $0.00 |
| Dec 1999 | $0.00 | - | - |
FAQ
- What is the all time high annual revenue for Oncolytics Biotech?
- What is the all time high quarterly revenue for Oncolytics Biotech?
- What is the all time high TTM revenue for Oncolytics Biotech?
What is the all time high annual revenue for Oncolytics Biotech?
Oncolytics Biotech all-time high annual revenue is $224.20 K
What is the all time high quarterly revenue for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly revenue is $305.40 K
What is the all time high TTM revenue for Oncolytics Biotech?
Oncolytics Biotech all-time high TTM revenue is $837.00 K